What is the current Price Target for the Fractyl Health stock?

The average Fractyl Health target price is $8.00. This is 601.75% higher than the current stock price. The highest price target is 777.19%, the lowest is 426.32%. 2 Analysts have issued a price target Fractyl Health 2026 .

How high will the Fractyl Health stock rise?

No reliable answer can be given as to how high the Fractyl Health stock will rise. The performance of stocks, including the Fractyl Health stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Fractyl Health stock today?

The performance of Fractyl Health stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Fractyl Health stock fall?

The decline in Fractyl Health stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Fractyl Health Forecast, price target & analysts

$1.14

1.72% yesterday

NYSE, Apr 03, 10:00 pm CET

ISIN

US35168W1036

Symbol

GUTS

Reports

Quarter | Annual

Sector

Health

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Fractyl Health Target price 2025 - Analyst rating & recommendation

Fractyl Health Classifications & Recommendation:

Buy

100%

Fractyl Health Price Target

Target Price	$8.00
Price	$1.14
Potential	601.75% register free of charge
Number of Estimates	2

	2 Analysts have issued a price target Fractyl Health 2026 . The average Fractyl Health target price is $8.00. This is 601.75% register free of charge higher than the current stock price. The highest price target is $10.00 777.19% register free of charge , the lowest is $6.00 426.32% register free of charge .
	A rating was issued by 3 analysts: 3 Analysts recommend Fractyl Health to buy, 0 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Fractyl Health stock has an average upside potential 2026 of 601.75% register free of charge . Most analysts recommend the Fractyl Health stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-1.44	-1.57
	93.18%	9.03%
P/E		negative

1 Analysts have issued a Fractyl Health forecast for earnings per share. The average Fractyl Health EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-1.44	93.18%
2025	$-1.57 9.03% Unlock
2026	$-2.39 52.23% Unlock

Current
2025	-0.73 6.41% Unlock
2026	-0.48 34.25% Unlock

Fractyl Health...

Current Fractyl Health Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Morgan Stanley	Locked ➜ Locked	Locked	Feb 03 2025

Analyst Rating	Date
Locked Morgan Stanley: Locked ➜ Locked	Feb 03 2025

Discover more stocks with a high price target

Coinbase Global, Inc. 83.53%

BioNTech SE - ADR 50.09%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now